检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张娅[1] 陈慧[2] 李灿东[3] 吴红霞[2] 林云钗[2] 洪丹丹[2] 王建军[2]
机构地区:[1]福建中医药大学中西医结合研究院,福州350108 [2]福建医科大学省立临床医学院,福州350001 [3]福建中医药大学中医证研究基地,福州350108
出 处:《中华中医药杂志》2011年第11期2521-2524,共4页China Journal of Traditional Chinese Medicine and Pharmacy
基 金:卫生部科学研究基金-福建省卫生教育联合攻关计划项目(No.WKJ2008-2-59)~~
摘 要:目的:探讨冠脉介入术后(PCI)气虚血瘀证与CYP2C19*2基因多态性的相关性。方法:405例行PCI成功的冠心病患者根据术后1周是否有气虚血瘀证表型分为气虚血瘀组(167例)和非气虚血瘀组(238例),抽取外周静脉血提取DNA,采用PCR-RFLP基因分析方法检测CYP2C19*2基因多态性。结果:单因素分析显示:气虚血瘀组CYP2C19*2基因突变型(GA+AA)明显高于非气虚血瘀组(χ2=15.945,P<0.001)。多因素Logistic回归分析显示:以非气虚血瘀组为参照系,调整诸混杂危险因素后,CYP2C19*2基因突变型(GA+AA)的相对危险度(OR)为2.465,95%Cl:[1.328,4.575],P=0.004。结论:冠脉介入术后CYP2C19*2基因突变患者可能易患气虚血瘀证。Objective:To approach the relationship between qi deficiency and blood stasis syndrome after Percutaneous Coronary Intervention and polymorphisms of CYP2C19*2 gene.Methods:405 CHD patients after receiving successful PCI were adopted in this study.Traditional Chinese Medicine(TCM) syndromes were differentiated into qi-deficiency blood-stasis type and non-qi-deficiency blood-stasis type after 7 days of standard antithrombotic therapy.All the subjects were genotyped for the polymorphisms of CYP2C19*2 by PCR-RFLP,and the genetic variants frequencies were compared in subjects.Results:The patient genotype distribution was in Hardy-Weinberg equilibrium.The univariate analysis showed that GA+AA was higher in qi-deficiency blood-stasis group than in non-qi-deficiency blood-stasis group(χ2=15.945,P0.001).After adjusting for common risk factors of CHD after PCI,logistic regression analysis indicated that the odds ratios(OR) of GA+AA(vs GG) genotype for qi deficiency and blood stasis syndrome was 2.465,95%Cl: [1.328,4.575],P=0.004,with the reference category of non-qi-deficiency blood-stasis syndrome.Conclusion:The GG+AA genotype may be some heritable susceptibility to disease of qi deficiency and blood stasis syndrome after PCI.
关 键 词:经皮冠状动脉介入术 气虚血瘀证 CYP2C19*2 基因多态性
分 类 号:R541.4[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.118.207.174